2166.6000 -31.90 (-1.45%)
NSE Oct 23, 2026 15:31 PM
Volume: 892.8K
 

2166.60
-1.45%
Geojit BNP Paribas
*over or under performance to benchmark index Glenmark Pharmaceuticals Ltd, which has a presence in over 80 countries, focuses on the generics, specialty and over-the-counter (OTC) segments, with a strong presence in diabetes, cardiovascular and oral contraceptives. In Q4FY26, Glenmark's normalized revenue grew 11.1% YoY to Rs. 3,616cr, driven...
Glenmark Pharmaceuticals Ltd. is trading below all available SMAs
More from Glenmark Pharmaceuticals Ltd.
Recommended